Page 12 - Bioscience Inc News Today

Fucosidosis Therapeutics MarketWith a CAGR of 6% from 2023 to 2033, the global Fucosidosis Therapeutics Market sales is anticipated to be worth US$ 10 million in 2023 and US$ 17.91 million by 2033. The Fucosidosis Therapeutics market increased at a 4% CAGR between 2018 and 2022.According to studies, fucosidosis is a...

While the ability to hire more employees is a milestone that should be celebrated, it does require that leaders make preparations to ensure long-term success.

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC are investigating the proposed merger of INVO Bioscience, Inc. with NAYA Biosciences Inc....

INVO | Complete INVO BioScience Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.

NEW YORK, Oct. 23, 2023 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential...

-- INVO Bioscience shares skyrocketed more than 406% in recent Monday trading after it said it has agreed to acquire NAYA Biosciences in an all-stock transaction. The company said NAYA Biosciences...

Gainers InMed Pharmaceuticals Inc. (NASDAQ: INM) shares climbed 169% to $1.56 after the company announced it selected a lead Alzheimer's drug candidate following proof-of-concept study data.

Gainers InMed Pharmaceuticals Inc. (NASDAQ:INM) shares climbed 169% to $1.56 after the company announced it selected a lead Alzheimer's...

INVO BioScience Inc (NASDAQ: INVO) shares traded lower on Tuesday.

TerrAscend (OTCMKTS:TSNDF – Get Free Report) and 10X Capital Venture Acquisition Corp. II (NASDAQ:VCXA – Get Free Report) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their dividends, valuation, analyst recommendations, profitability, risk, earnings and institutional ownership. Earnings and Valuation This […]